Search - tctmd.com

Displaying 1 - 20 of 73

Sort: Relevancy | Date

Video

TVT 2019: Reactions From the Surgical Community

June 13, 2019

Video

TVT 2019: Reactions From the Cardiology Community

June 13, 2019

Video

TVT 2019: Outcomes Following Transcarotid Versus Transpical/Transaortic Access for Transcatheter Aortic Valve Replacement: Results from the Transcatheter Valve Therapy (TVT) Registry

June 14, 2019

Video

» Live Case

TVT 2019: Live Case #8: NYP/Columbia — TAVR - Lotus

June 14, 2019

Video

» Live Case

TVT 2019: Live Case #7: University Hospital Bonn / Heart Center Bonn — TAVR - Lotus

June 14, 2019

Video

» Live Case

TVT 2019: Live Case #4: Emory Structural Heart & Valve Center — TAVR - Valve-in-Valve (Basilica)

June 13, 2019

Video

» Live Case

TVT 2019: Live Case #15: NYP/Columbia — TAVR Sapien Ultra

June 25, 2019

Video

» Live Case

TVT 2019: Live Case #14: Providence Heart and Vascular Institute — Transcarotid - TAVR

June 25, 2019

Video

» Live Case

TVT 2019: Live Case #12:Cedars-Sinai Medical Center — TAVR - BAV AR

June 14, 2019

Video

» Live Case

TVT 2019: Live Case #11: NYP/Columbia — TAVR - Evolut Valve-in-Valve

June 14, 2019

Video

TVT 2019: Highlights From the Evolut Low-Risk Trial

June 13, 2019

Video

TVT 2019: Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

June 14, 2019

Video

TVT 2019: Functional Status After Transcatheter and Surgical Aortic Valve Replacement: A Two-Year Analysis From the SURTAVI Trial

June 15, 2019

Video

TVT 2019: Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

June 14, 2019

Video

TVT 2019: Do We Need a Randomized Trial in Bicuspid Aortic Valve Disease?

June 13, 2019

Video

TVT 2019: Disparities in the Treatment of Aortic Stenosis: Race, Gender, and Referring Physician Biases

June 13, 2019

Video

TVT 2019: Access to Coronaries After TAVR: The Next Big Thing?

June 13, 2019

Video

» Interview

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo Versus the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

September 18, 2022

Video

» Topical Discussion

The Impact of Valve Flow Dynamics on Disease Regression and Outcomes After TAVR

November 18, 2024

Video

» Topical Discussion

The ARTIST Study and the Future of TAVR for Aortic Regurgitation

December 5, 2024

Advertisement

TVT 2019: Reactions From the Surgical Community

TVT 2019: Reactions From the Cardiology Community

TVT 2019: Outcomes Following Transcarotid Versus Transpical/Transaortic Access for Transcatheter Aortic Valve Replacement: Results from the Transcatheter Valve Therapy (TVT) Registry

TVT 2019: Live Case #8: NYP/Columbia — TAVR - Lotus

TVT 2019: Live Case #7: University Hospital Bonn / Heart Center Bonn — TAVR - Lotus

TVT 2019: Live Case #4: Emory Structural Heart & Valve Center — TAVR - Valve-in-Valve (Basilica)

TVT 2019: Live Case #15: NYP/Columbia — TAVR Sapien Ultra

TVT 2019: Live Case #14: Providence Heart and Vascular Institute — Transcarotid - TAVR

TVT 2019: Live Case #12:Cedars-Sinai Medical Center — TAVR - BAV AR

TVT 2019: Live Case #11: NYP/Columbia — TAVR - Evolut Valve-in-Valve

TVT 2019: Highlights From the Evolut Low-Risk Trial

TVT 2019: Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

TVT 2019: Functional Status After Transcatheter and Surgical Aortic Valve Replacement: A Two-Year Analysis From the SURTAVI Trial

TVT 2019: Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

TVT 2019: Do We Need a Randomized Trial in Bicuspid Aortic Valve Disease?

TVT 2019: Disparities in the Treatment of Aortic Stenosis: Race, Gender, and Referring Physician Biases

TVT 2019: Access to Coronaries After TAVR: The Next Big Thing?

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo Versus the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

The Impact of Valve Flow Dynamics on Disease Regression and Outcomes After TAVR

The ARTIST Study and the Future of TAVR for Aortic Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content